Qube Research & Technologies (QRT)’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,825
Closed -$154K 3358
2024
Q2
$154K Buy
7,825
+7,387
+1,687% +$140K ﹤0.01% 2505
2024
Q1
$7.89K Sell
438
-5,357
-92% -$97.2K ﹤0.01% 3835
2023
Q4
$98.2K Buy
5,795
+1,406
+32% +$27.9K ﹤0.01% 3103
2023
Q3
$87.2K Buy
+4,389
New +$83.1K ﹤0.01% 2700

Other funds holding BTAL

Qube Research & Technologies (QRT)'s BTAL Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2024, closing a stake of 7,825 shares — an estimated $154K sold.

Qube Research & Technologies (QRT) first reported a position in BTAL in Q3 2023 and held it in 4 quarters. The position peaked at $154K in Q2 2024. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 7,825 AGF US Market Neutral Anti-Beta Fund shares in Q3 2024, an estimated $154K.
  • Qube Research & Technologies (QRT) first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s AGF US Market Neutral Anti-Beta Fund position peaked at $154K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.